Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (22548)	6/19/1998 10:24:00 PM
From: WTDEC	Read Replies (2) of 32384

Henry, here is a segment of today's PR from the Canadian company SRGN seems to have a relationship with: "At the end of February, DiagnoCure concluded a licensing agreement with Seragen Inc. [OTC BB:SRGN - news] of Boston, which specializes in fusion proteins, as well as a collaborative research agreement with Dr. John Murphy, a world renowned expert in protein engineering. Following the signing of the agreement with Dr. Murphy, DiagnoCure has set up a research program aimed at integrating an unexploited area of Seragen's fusion protein technology " Do you, or anyone else, know if LGND gets a royalty from this research program? Regards, Walter PS: What is JAGS? I assume it is a soccer meet, so good luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next